RSS   Newsletter   Contact   Advertise with us

LivaNova appoints Thad Huston as CFO

Share on Twitter Share on LinkedIn
Staff Writer | London, United Kingdom | May 17, 2017
LivaNovaMay 17, 2017, London, United Kingdom - LivaNova, a medical technology company, announced Thad Huston will join the company as its new chief financial officer effective May 20, 2017.
Mr. Huston is a highly strategic global finance executive who joins LivaNova after more than 25 years at Johnson & Johnson (J&J), having most recently served as Group Chief Financial Officer, Medical Devices.

During his tenure at J&J, Mr. Huston held various senior roles, including: President of J&Jā€™s Xian-Janssen Pharmaceuticals division in China; Vice President ā€“ Finance, Chief Financial Officer and Chief Operations Officer in J&J Pharmaceutical Research and Development; as well as Vice President ā€“ Finance and Chief Financial Officer at Ortho-McNeil Pharmaceuticals.

Prior to this, Mr. Huston held senior financial roles at various J&J locations in the U.S., China, Belgium, Russia and Hungary. ā– 

 LATEST MOVES FROM United Kingdom